Stockreport

Eli Lilly's US$7b Kelonia Deal Reshapes Oncology And Valuation Story [Yahoo! Finance]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF Eli Lilly (NYSE:LLY) has agreed to acquire Kelonia Therapeutics in a transaction valued at up to $7 billion. The deal brings Kelonia's in vivo CAR-T gene therapy plat [Read more]